Nyxoah SA
NYXH
View Detailed Chart
4.940USD
+0.160+3.35%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
184.93MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.35%
5 Days
-5.73%
1 Month
-21.21%
6 Months
-55.29%
Year to Date
-38.25%
1 Year
-42.62%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-19Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. Despite strong stock market performance and technicals, the fundamentals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
13.200
Target Price
+176.15%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 51.54% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.37M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 96.10.
Overvalued
The company’s latest PE is -2.34, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 25.16M shares, decreasing 10.70% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.28.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Ticker SymbolNYXH
CompanyNyxoah SA
CEOMr. Olivier Taelman
Websitehttps://www.nyxoah.com/
Related Instruments
-0.32%
+0.66%
-0.41%
-1.01%
-0.46%
-0.19%
-0.04%
-1.02%
+1.23%
-0.64%
-1.80%
-0.27%
-2.84%
-1.19%
-0.78%
-0.30%
+0.98%
-0.72%
-1.25%
-3.23%
